Matches in Wikidata for { <http://www.wikidata.org/entity/Q80470323> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q80470323 description "artículu científicu espublizáu en xunu de 2007" @default.
- Q80470323 description "scientific article published on 01 June 2007" @default.
- Q80470323 description "wetenschappelijk artikel" @default.
- Q80470323 description "наукова стаття, опублікована в червні 2007" @default.
- Q80470323 name "Alemtuzumab (Campath 1H) induction with tacrolimus monotherapy is safe for high immunological risk renal transplantation" @default.
- Q80470323 name "Alemtuzumab (Campath 1H) induction with tacrolimus monotherapy is safe for high immunological risk renal transplantation" @default.
- Q80470323 type Item @default.
- Q80470323 label "Alemtuzumab (Campath 1H) induction with tacrolimus monotherapy is safe for high immunological risk renal transplantation" @default.
- Q80470323 label "Alemtuzumab (Campath 1H) induction with tacrolimus monotherapy is safe for high immunological risk renal transplantation" @default.
- Q80470323 prefLabel "Alemtuzumab (Campath 1H) induction with tacrolimus monotherapy is safe for high immunological risk renal transplantation" @default.
- Q80470323 prefLabel "Alemtuzumab (Campath 1H) induction with tacrolimus monotherapy is safe for high immunological risk renal transplantation" @default.
- Q80470323 P1433 Q80470323-1FA6F296-80E7-488D-89F5-D9C851AEB794 @default.
- Q80470323 P1476 Q80470323-1014C0DF-969B-4636-B9B7-772772C246BD @default.
- Q80470323 P2093 Q80470323-2147DCE0-07C5-4B93-9DAA-B2C180AE2EAB @default.
- Q80470323 P2093 Q80470323-27A33F06-8205-4B57-BF6E-E71252DA5E2D @default.
- Q80470323 P2093 Q80470323-85494A26-6494-454B-AD9E-2AF2A0B3EC56 @default.
- Q80470323 P2093 Q80470323-8A1E1398-9590-4F9E-B68E-192E612C4485 @default.
- Q80470323 P2093 Q80470323-D8D9A206-2837-4F11-920C-3C0C7F3131E3 @default.
- Q80470323 P304 Q80470323-2F0A15DB-FB31-4F6C-B1D4-0128FF5D2B4F @default.
- Q80470323 P31 Q80470323-A7D0E6FF-DB4E-4E7B-9039-262D7BBDD483 @default.
- Q80470323 P356 Q80470323-852AFCDC-90BC-4816-AE8C-24898B8276A0 @default.
- Q80470323 P407 Q80470323-BA2460E8-CC0B-451C-8AE4-9A6B04B2D2ED @default.
- Q80470323 P433 Q80470323-809BEF00-55D8-49A2-8641-380897D53A75 @default.
- Q80470323 P478 Q80470323-A7A375C4-B93E-4959-A2A1-641AB7B981BE @default.
- Q80470323 P50 Q80470323-E313FCF5-11D9-4AF8-9A39-8AFD31B0A687 @default.
- Q80470323 P577 Q80470323-699E7832-AACE-45DB-B211-821A15736575 @default.
- Q80470323 P698 Q80470323-CC188DAC-1083-4B11-AA86-DD4B58741CA1 @default.
- Q80470323 P356 01.TP.0000263344.53000.A1 @default.
- Q80470323 P698 17565326 @default.
- Q80470323 P1433 Q15730500 @default.
- Q80470323 P1476 "Alemtuzumab (Campath 1H) induction with tacrolimus monotherapy is safe for high immunological risk renal transplantation" @default.
- Q80470323 P2093 "Jacqueline A Lappin" @default.
- Q80470323 P2093 "Kristene K Gugliuzza" @default.
- Q80470323 P2093 "Philip G Thomas" @default.
- Q80470323 P2093 "Smita Vaidya" @default.
- Q80470323 P2093 "Srinivasan Rajaraman" @default.
- Q80470323 P304 "1509-1512" @default.
- Q80470323 P31 Q13442814 @default.
- Q80470323 P356 "10.1097/01.TP.0000263344.53000.A1" @default.
- Q80470323 P407 Q1860 @default.
- Q80470323 P433 "11" @default.
- Q80470323 P478 "83" @default.
- Q80470323 P50 Q51801602 @default.
- Q80470323 P577 "2007-06-01T00:00:00Z" @default.
- Q80470323 P698 "17565326" @default.